Terminated PHASE2 INTERVENTIONAL 1-arm NCT03868839

Telmisartan Pilot Study on Treatment Resistant Schizophrenia

An Open-label Feasibility Trial of Adjunctive Telmisartan in Patients With Treatment Resistant Schizophrenia

Sponsor: Xiaoduo Fan

Conditions Schizo Affective Disorder Schizophrenia Treatment-resistant Schizophrenia

Updated 9 times since 2019 Last updated: Feb 7, 2022 Started: Feb 1, 2019 Primary completion: Oct 7, 2020 Completion: Oct 7, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of funding

This PHASE2 trial investigates Schizo Affective Disorder and Schizophrenia and is currently terminated or withdrawn. Xiaoduo Fan leads this study, which shows 9 recorded versions since 2019 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE2
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE2
Apr 2022 — Dec 2022 [monthly]

Terminated PHASE2

Status: Active Not Recruiting → Terminated

▶ Show 4 earlier versions

Feb 2021 — Apr 2022 [monthly]

Active Not Recruiting PHASE2
Jan 2021 — Feb 2021 [monthly]

Active Not Recruiting PHASE2
Apr 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Apr 2019 — Apr 2020 [monthly]

Recruiting PHASE2

First recorded

Feb 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xiaoduo Fan

Data source: University of Massachusetts, Worcester

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Worcester, United States